Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Growth Factors & Cytokines

Recombinant Human TNF-β

0 ComentariosSubmit a Review

Detalles del Producto

Nùmero de Catalogo 300-01B
Descripcion
Recombinant Human TNF-β

TNF-β is a potent mediator of inflammatory and immune responses. It belongs to the TNF family of ligands, and signals through TNFR1 and TNFR2. TNF-β is produced by activated T and B lymphocytes, and has similar activities to TNF-α. Like TNF-α, TNF-β is involved in the regulation of various biological processes, including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. TNF-β is secreted as a soluble polypeptide, but can form heterotrimers with lymphotoxin-β, which effectively anchors the TNF-β to the cell surface. TNF-β is cytotoxic to a wide range of tumor cells. Recombinant Human TNF-β is a secreted 172 amino acid protein (18.6 kDa) which forms an active non-disulfide-linked homotrimer structure in solution.

Source: E.coli

Synonyms: Tumor Necrosis Factor-β, TNFSF1B, Lymphotoxin-alpha (LT-α)

AA Sequence: MLPGVGLTPS AAQTARQHPK MHLAHSTLKP AAHLIGDPSK QNSLLWRANT DRAFLQDGFS LSNNSLLVPT SGIYFVYSQV VFSGKAYSPK ATSSPLYLAH EVQLFSSQYP FHVPLLSSQK MVYPGLQEPW LHSMYHGAAF QLTQGDQLST HTDGIPHLVL SPSTVFFGAF AL

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin-D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 107 units/mg.

Recombinant Human TNF-β Biological Activity Graph

Calculated Molecular Weight: 18.6 kDa

Accession Number: P01374

Gene ID: 4049

Endotoxin: Endotoxin level is < 0.1 ng/ug of protein (< 1 EU/ug)

Note:

1mg will be provided as 2x500μg.

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

Primer autor
Chan, L C
Titulo
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.
Citar
The Journal of Clinical Investigation; 129(8) pg3324-3338
PudMed id
Primer autor
Park, M K
Titulo
Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.
Citar
Scientific Reports; 9(1) pg2372
PudMed id
Primer autor
Shee, K
Titulo
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.
Citar
The Journal of Experimental Medicine; 215(3) pg895-910
PudMed id